EXCHANGE AND BLEACH DISTRIBUTION PROGRAM STUDIES

1992年7月，作为“ADAMHA重组法案”的一部分，国会 呼吁卫生与公众服务部部长，通过 国家药物滥用研究所要求国家药物滥用研究院 科学界签订合同，以评估注射器的影响 关于毒品使用和吸毒率的交流和漂白剂分发方案 艾滋病和其他疾病。 国会使用的具体语言是“一个 研究或研究，以确定以下内容，”这也 包括本项目的目标： L.这些方案直接或间接促进 通过提供信息或设备（或两者）滥用药物 关于这种虐待的不良健康后果可能 最小化 2.在个人参与方案的情况下， 在被接纳之前曾滥用药物的个人 没有参与这些活动的人的数量和人数 在此之前，这种行为。 3.参与这些计划的程度改变了任何 构成感染获得性免疫的重大风险的行为 缺乏综合征或肝炎，或传播任何一种 疾病 4.提供转诊治疗此类疾病的方案数量 虐待和不提供这种转介的方案的数量。 5.计划安全处理使用过的皮下注射器的程度 和针头。

In July of 1992 and as part of the "ADAMHA Reorganization Act," Congress called for the Secretary of Health and Human Services, through the National Institute on Drug Abuse, to request the National Academy of Sciences to enter into a contract to evaluate the impact of syringe exchange and bleach distribution programs on drug use and the incidence of AIDS and other diseases. The specific language used by Congress is "a study or studies to make determinations of the following," which also comprise the objectives of this project: l. The extent to which the programs promote, directly or indirectly, the abuse of drugs through providing information or devices (or both) regarding in which the adverse health consequences of such abuse can minimized. 2. In the case of individuals participating in programs, the number of individuals who have engaged in the abuse of drugs prior to admission to the programs and the number of individuals who have not engaged in such abuse prior to such admission. 3. The extent to which participation in the programs has altered any behaviors constituting a substantial risk of contracting acquired immune deficiency syndrome or hepatitis, or of transmitting either of the diseases. 4. The number of programs that provide referrals for the treatment of such abuse and the number of programs that do not provide such referrals. 5. The extent to which programs safely dispose of used hypodermic syringes and needles.